Thematic area:
Novel Sensors
Product:
A minimally invasive subdermal photonic sensor that continuously measures interstitial fluid pressure to detect early fluid overload, enabling timely intervention in heart failure and kidney failure patients.
Market:
Competes in the $4.9B remote cardiac monitoring market, with an initial US opportunity worth ~$320M. Designed for nephrologists, cardiologists, and home monitoring programmes.
Fit:
Current detection relies on patient self-monitoring (e.g., weight) which is highly unreliable. BioPressure provides a first-in-class, accurate alternative with strong clinician demand, improving outcomes and reducing costly hospital admissions.
